Literature DB >> 6448900

Interaction of reovirus with cell surface receptors. II. Generation of suppressor T cells by the hemagglutinin of reovirus type 3.

A Fontana, H L Weiner.   

Abstract

In studying reovirus interactions with lymphocytes, we have found that reovirus type 3, but not type 1, inhibits the in vitro proliferative response of murine splenic lymphocytes to concanavalin A (Con A). By analyzing recombinant clones containing genes from both reovirus types 1 and 3, we found that the S1 gene, the gene that encodes the viral hemagglutinin, is responsible for the inhibitory effect. In addition we found that type 3, but not type 1, generates suppressor T cells in vitro capable of suppressing Con A proliferation. By analyzing recombinant clones, we also found that the viral hemagglutinin is responsible for the generation of suppressor T cells by reovirus type 3. These effects were observed whether UV-inactivated or live virus was used. Reovirus type 3 inhibition of the proliferative response of murine splenic lymphocytes to Con A was blocked by anti-reovirus type 3 antibody but not by anti-reovirus type 1 antibody. Antiviral antibody had no effect on the ability of reovirus type 3 induced suppressor cells to inhibit Con A proliferation. We have previously demonstrated a receptor on murine lymphocytes for the hemagglutinin of reovirus type 3, and our results suggest that the in vitro suppression of Con A proliferation of murine lymphocytes by reovirus type 3 is secondary to the interaction of the viral hemagglutinin with a receptor on the surface of murine lymphocytes, which results in the generation of functionally active suppressor T cells.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6448900

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

1.  Binding of type 3 reovirus by a domain of the sigma 1 protein important for hemagglutination leads to infection of murine erythroleukemia cells.

Authors:  D H Rubin; J D Wetzel; W V Williams; J A Cohen; C Dworkin; T S Dermody
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

Review 2.  Mechanisms of virus-induced immune suppression.

Authors:  M A Wainberg; E L Mills
Journal:  Can Med Assoc J       Date:  1985-06-01       Impact factor: 8.262

3.  Sequences of the S1 genes of the three serotypes of reovirus.

Authors:  L W Cashdollar; R A Chmelo; J R Wiener; W K Joklik
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

4.  Evidence that the sigma 1 protein of reovirus serotype 3 is a multimer.

Authors:  R Bassel-Duby; M L Nibert; C J Homcy; B N Fields; D G Sawutz
Journal:  J Virol       Date:  1987-06       Impact factor: 5.103

5.  Molecular cloning and sequencing of the reovirus (serotype 3) S1 gene which encodes the viral cell attachment protein sigma 1.

Authors:  L Nagata; S A Masri; D C Mah; P W Lee
Journal:  Nucleic Acids Res       Date:  1984-11-26       Impact factor: 16.971

Review 6.  Anti-idiotypic antibodies as probes of cell surface receptors.

Authors:  G N Gaulton; M S Co; H D Royer; M I Greene
Journal:  Mol Cell Biochem       Date:  1984-11       Impact factor: 3.396

Review 7.  Virus-binding receptors: similarities to immune receptors as determined by anti-idiotypic antibodies.

Authors:  J T Nepom; M Tardieu; R L Epstein; J H Noseworthy; H L Weiner; J Gentsch; B N Fields; M I Greene
Journal:  Surv Immunol Res       Date:  1982

Review 8.  Structure and function of the reovirus genome.

Authors:  W K Joklik
Journal:  Microbiol Rev       Date:  1981-12

9.  Interleukin 1 activity in the synovial fluid of patients with rheumatoid arthritis.

Authors:  A Fontana; H Hengartner; E Weber; K Fehr; P J Grob; G Cohen
Journal:  Rheumatol Int       Date:  1982       Impact factor: 2.631

10.  The effects of T-cell growth factor and virus purification on virus-mediated inhibition of lymphocyte mitogenesis.

Authors:  M A Wainberg; R G Margolese
Journal:  Clin Exp Immunol       Date:  1982-04       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.